Hemodialysis vascular access morbidity.
HI Feldman, S Kobrin… - Journal of the American …, 1996 - journals.lww.com
Complications associated with hemodialysis vascular access represent one of the most
important sources of morbidity among ESRD patients in the United States today. In this …
important sources of morbidity among ESRD patients in the United States today. In this …
[HTML][HTML] Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review
TS Huber, JW Carter, RL Carter, JM Seeger - Journal of vascular surgery, 2003 - Elsevier
OBJECTIVE: Patency rates for autogenous accesses are presumed to be better than for
polytetrafluoroethylene (PTFE) accesses, although the strength of the supporting evidence is …
polytetrafluoroethylene (PTFE) accesses, although the strength of the supporting evidence is …
[HTML][HTML] Type of vascular access and mortality in US hemodialysis patients
RK Dhingra, EW Young, TE Hulbert-Shearon… - Kidney international, 2001 - Elsevier
Type of vascular access and mortality in US hemodialysis patients. Background Vascular
access (VA) complications account for 16 to 25% of hospital admissions. This study tested …
access (VA) complications account for 16 to 25% of hospital admissions. This study tested …
[HTML][HTML] Infectious complications of the hemodialysis access
GM Nassar, JC Ayus - Kidney international, 2001 - Elsevier
Infectious complications of the hemodialysis access. Infectious complications of the vascular
access are a major source of morbidity and mortality among hemodialysis (HD) patients …
access are a major source of morbidity and mortality among hemodialysis (HD) patients …
Percutaneous transvenous angioplasty in the treatment of vascular access stenosis
GA Beathard - Kidney international, 1992 - Elsevier
Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. This
study was undertaken to evaluate percutaneous transvenous angioplasty (PTVA) for the …
study was undertaken to evaluate percutaneous transvenous angioplasty (PTVA) for the …
Canadian hemodialysis morbidity study
The objective of this study was to determine the probabilities of specific morbid events or
death among patients with end-stage renal disease (ESRD) treated by hemodialysis. A …
death among patients with end-stage renal disease (ESRD) treated by hemodialysis. A …
Vascular access for hemodialysis. Patency rates and results of revision.
SB Palder, RL Kirkman, AD Whittemore… - Annals of …, 1985 - ncbi.nlm.nih.gov
Abstract Over a 4-year interval, 324 arteriovenous conduits were created in 256 patients with
end-stage renal disease as access for chronic hemodialysis. These included 154 Cimino …
end-stage renal disease as access for chronic hemodialysis. These included 154 Cimino …
Prevention of hemodialysis fistula thrombosis. Early detection of venous stenoses
SJ Schwab, JR Raymond, M Saeed, GE Newman… - Kidney international, 1989 - Elsevier
Prevention of hemodialysis fistula thrombosis. Early detection of venous stenoses. Venous
dialysis pressures were measured consecutively in 168 chronic hemodialysis patients for …
dialysis pressures were measured consecutively in 168 chronic hemodialysis patients for …
Vascular access: concepts for the 1990s.
PY Fan, SJ Schwab - Journal of the American Society of …, 1992 - journals.lww.com
Modern hemodialysis requires repeated reliable access to blood vessels capable of
providing rapid extracorporeal blood flow. This necessity for reliable access to the circulation …
providing rapid extracorporeal blood flow. This necessity for reliable access to the circulation …
Vascular access for hemodialysis
SJ Schwab - Kidney international, 1999 - kidney-international.org
DISCUSSION D r. S teve J. S chwab (Vice-Chairman, Department of Medicine, Duke
University Medical Center, and Professor of Medicine, Duke University School of Medicine …
University Medical Center, and Professor of Medicine, Duke University School of Medicine …